Fuchs CS - Search Results

1

Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, Morikawa T, Nosho K, Abril-Rodriguez G, Connolly C, Escuin-Ordinas H, Geybels MS, Grady WM, Hsu L, Hu-Lieskovan S, Huyghe JR, Kim YJ, Krystofinski P, Leiserson MDM, Montoya DJ, Nadel BB, Pellegrini M, Pritchard CC, Puig-Saus C, Quist EH, Raphael BJ, Salipante SJ, Shin DS, Shinbrot E, Shirts B, Shukla S, Stanford JL, Sun W, Tsoi J, Upfill-Brown A, Wheeler DA, Wu CJ, Yu M, Zaidi SH, Zaretsky JM, Gabriel SB, Lander ES, Garraway LA, Hudson TJ, Fuchs CS, Ribas A, Ogino S, Peters U. Grasso CS, et al. Among authors: fuchs cs. Cancer Discov. 2018 Jun;8(6):730-749. doi: 10.1158/2159-8290.CD-17-1327. Epub 2018 Mar 6. Cancer Discov. 2018. PMID: 29510987 Free PMC article.

2

Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.

Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Mod Pathol. 2006 Jan;19(1):59-68. doi: 10.1038/modpathol.3800482. Mod Pathol. 2006. PMID: 16118624 Free article.

3

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Clin Cancer Res. 2005 Sep 15;11(18):6650-6. doi: 10.1158/1078-0432.CCR-05-0738. Clin Cancer Res. 2005. PMID: 16166444 Clinical Trial.

4

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.

Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Gut. 2006 Jul;55(7):1000-6. doi: 10.1136/gut.2005.082933. Epub 2006 Jan 11. Gut. 2006. PMID: 16407376 Free PMC article.

5

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Mod Pathol. 2006 Aug;19(8):1083-90. doi: 10.1038/modpathol.3800618. Epub 2006 May 12. Mod Pathol. 2006. PMID: 16699497 Free article.

6

Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer.

Meyerhardt JA, Heseltine D, Ogino S, Clark JW, Enzinger PC, Ryan DP, Earle CC, Zhu AX, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Clin Colorectal Cancer. 2006 May;6(1):59-65. doi: 10.3816/CCC.2006.n.022. Clin Colorectal Cancer. 2006. PMID: 16796793 Clinical Trial.

7

Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Neoplasia. 2006 Jun;8(6):458-64. doi: 10.1593/neo.06247. Neoplasia. 2006. PMID: 16820091 Free PMC article.

8

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.

Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. J Pathol. 2006 Oct;210(2):147-54. doi: 10.1002/path.2030. J Pathol. 2006. PMID: 16850502

9

Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.

Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. Am J Surg Pathol. 2006 Sep;30(9):1175-83. doi: 10.1097/01.pas.0000213266.84725.d0. Am J Surg Pathol. 2006. PMID: 16931963

10

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.

Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. Ogino S, et al. Among authors: fuchs cs. J Mol Diagn. 2006 Nov;8(5):582-8. doi: 10.2353/jmoldx.2006.060082. J Mol Diagn. 2006. PMID: 17065427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

748 results

Search Page